Saad J. Kenderian, M.B., Ch.B.
Hematologist
Internist
Oncologist
Parent EE, Gleba JJ, Knight JA,
Kenderian SJ
, Copland JA 3rd, Cai H. Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer. Mol Imaging Biol. 2024 Aug 22 [Epub ahead of print]
View PubMed
Khurana A, Rosenthal AC, Mohty R, Gaddam M, Bansal R, Hathcock MA, Nedved AN, Durani U, Iqbal M, Wang Y, Paludo J, Villasboas JC, Dingli D, Kourelis T, Leung N, Alkhateeb H, Ruff MW, Gallo de Moraes A, Vergidis P, Herrmann J,
Kenderian SS
, Bennani NN, Johnston PB, Ansell SM, Lin Y. Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management. Blood Cancer J 2024 Aug 12; 14 (1):136
View PubMed
Gimblet GR, Houson HA, Whitt J, Reddy P, Copland JA,
Kenderian SS
, Szkudlinski MW, Jaskula-Sztul R, Lapi SE. PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [(89)Zr]Zr-TR1402. Mol Pharm. 2024 Aug 5; 21 (8):3889-3896 Epub 2024 July 08
View PubMed
Gardner RA, White C, Elsallab M, Farnia S, Fraint E, Grilley B, Bateman-House A, Grupp SA,
Kenderian S
, Locke FL, Nikiforow S, Oluwole OO, Rouce RH, Spiegel J, Shah NN, Sharma A, Komanduri K, Gill S. ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies. Transplant Cell Ther. 2024 Aug; 30 (8):776-787 Epub 2024 May 16
View PubMed
Wang H, Tian S, Secreto CR, Sinha S, Shi M, Call T, Wang Y, Parikh SA,
Kenderian SS
, He R, Leis JF, VanDyke DL, Klee EW, Slager SL, Braggio E, Yan H, Ding W. Clonal dynamics of Richter transformation in chronic lymphocytic leukemia. Hematol Oncol 2024 Jul; 42 (4):e3282
View PubMed
Hampel PJ, Swaminathan M, Rogers KA, Parry EM, Burger JA, Davids MS, Ding W, Ferrajoli A, Hyak JM, Jain N,
Kenderian SS
, Wang Y, Wierda WG, Woyach JA, Parikh SA, Thompson PA. A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood Adv. 2024 May 28; 8 (10):2342-2350
View PubMed
Sirpilla O, Sakemura RL, Hefazi M, Huynh TN, Can I, Girsch JH, Tapper EE, Cox MJ, Schick KJ, Manriquez-Roman C, Yun K, Stewart CM, Ogbodo EJ, Kimball BL, Mai LK, Gutierrez-Ruiz OL, Rodriguez ML, Gluscevic M, Larson DP, Abel AM, Wierson WA, Olivier G, Siegler EL,
Kenderian SS
. Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression. Nat Biomed Eng. 2024 Apr; 8(4):443-460.
View PubMed
Gurney M, Baranwal A, Rosenthal A, Kharfan-Dabaja MA,
Kenderian SS
, Lin Y, Shah MV. Features and Factors Associated With Myeloid Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. JAMA Oncol. 2024 Apr 1; 10 (4):532-535
View PubMed
Christopoulos G, Attia ZI, Achenbach SJ, Rabe KG, Call TG, Ding W, Leis JF, Muchtar E,
Kenderian SS
, Wang Y, Hampel PJ, Koehler AB, Kay NE, Kapoor P, Slager SL, Shanafelt TD, Noseworthy PA, Friedman PA, Herrmann J, Parikh SA. Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic Leukemia. JACC CardioOncol. 2024 Apr; 6 (2):251-263 Epub 2024 Apr 16
View PubMed
Chohan KL, Bansal R, Hathcock MA, Paludo J, Bennani NN, Johnston PB, Khurana A, Durani U, Wang Y, Ruff MW, Villasboas Bisneto JC, Ansell SM, Lin Y,
Kenderian SS
. Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience. Leuk Lymphoma. 2024 Mar; 65 (3):389-393 Epub 2023 Nov 30
View PubMed
Sakemura RL, Manriquez Roman C, Horvei P, Siegler EL, Girsch JH, Sirpilla OL, Stewart CM, Yun K, Can I, Ogbodo EJ, Adada MM, Bezerra ED, Kankeu Fonkoua LA, Hefazi M, Ruff MW, Kimball BL, Mai LK, Huynh TN, Nevala WK, Ilieva K, Augsberger C, Patra-Kneuer M, Schanzer J, Endell J, Heitmüller C, Steidl S, Parikh SA, Ding W, Kay NE, Nowakowski GS,
Kenderian SS
. CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS. Blood. 2024 Jan 18; 143(3):258-271.
View PubMed
Gimblet GR, Whitt J, Houson HA, Lin D, Guenter R, Rao TC, Wang D, Ness J, Gonzalez ML, Murphy MS, Gillis A, Chen H, Copland JA,
Kenderian SS
, Lloyd RV, Szkudlinski MW, Lapi SE, Jaskula-Sztul R. Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer. Surgery. 2024 Jan; 175 (1):199-206 Epub 2023 Oct 31
View PubMed
Kosydar SR, Parikh SA, Lester SC, Rabe KG, Ding W, Burlile JF,
Kenderian SS
, Wang Y, Muchtar E, Koehler AB, Schwager SM, Slager SL, Kay NE, Call TG, Breen WG, Hampel PJ. Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment. Am J Hematol 2023 Nov; 98 (11):E318-E321 Epub 2023 Aug 24
View PubMed
Yun K, Siegler EL,
Kenderian SS
. Who wins the combat, CAR or TCR? Leukemia. 2023 Oct; 37(10):1953-1962. Epub 2023 Aug 25.
View PubMed
Sakemura RL, Hefazi M, Cox MJ, Siegler EL, Sinha S, Hansen MJ, Stewart CM, Feigin JM, Manriquez Roman C, Schick KJ, Can I, Tapper EE, Horvei P, Adada MM, Bezerra ED, Kankeu Fonkoua LA, Ruff MW, Forsman CL, Nevala WK, Boysen JC, Tschumper RC, Grand CL, Kuchimanchi KR, Mouritsen L, Foulks JM, Warner SL, Call TG, Parikh SA, Ding W, Kay NE,
Kenderian SS
. AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells. Cancer Immunol Res. 2023 Sep 01; 11(9):1222-1236.
View PubMed
Siddiqi T, Maloney DG,
Kenderian SS
, Brander DM, Dorritie K, Soumerai J, Riedell PA, Shah NN, Nath R, Fakhri B, Stephens DM, Ma S, Feldman T, Solomon SR, Schuster SJ, Perna SK, Tuazon SA, Ou SS, Papp E, Peiser L, Chen Y, Wierda WG. Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study. Lancet. 2023 Aug 19; 402 (10402):641-654 Epub 2023 June 06
View PubMed
Chohan KL, Siegler EL,
Kenderian SS
. CAR-T Cell Therapy: the Efficacy and Toxicity Balance. Curr Hematol Malig Rep. 2023 Apr; 18(2):9-18. Epub 2023 Feb 10.
View PubMed
Singhal S, Saadeh SS, Durani U, Kansagra A, Alkhateeb HB, Shah MV, Mangaonkar A,
Kenderian S
, Hashmi S, Patnaik MV, Litzow MR, Hogan WJ. Allogeneic Hematopoietic Stem Cell Transplantation in the Outpatient Setting: The Mayo Clinic Experience. Transplant Cell Ther. 2023 Mar; 29 (3):183.e1-183.e6 Epub 2022 Dec 28
View PubMed
Manriquez Roman C, Sakemura RL, Kimball BL, Jin F, Khadka RH, Adada MM, Siegler EL, Johnson AJ,
Kenderian SS
. Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-derived Xenograft Mouse Model. J Vis Exp. 2023 Feb 10; (192).
View PubMed
Acosta-Medina AA, Johnson IM, Bansal R, Hathcock M,
Kenderian SJ
, Durani U, Khurana A, Wang Y, Paludo J, Villasboas JC, Bennani NN, Johnston PB, Ansell SM, Lin Y, Alkhateeb HB. Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma. Blood Cancer J 2023 Jan 5; 13 (1):7 Epub 2023 Jan 05
View PubMed
Hampel PJ, Rabe KG, Call TG, Ding W, Leis JF,
Kenderian SS
, Muchtar E, Wang Y, Koehler AB, Parrondo R, Schwager SM, Shi M, Braggio E, Slager SL, Kay NE, Parikh SA. Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia. Br J Haematol. 2022 Oct; 199 (2):239-244 Epub 2022 July 16
View PubMed
Perales MA, Anderson LD Jr, Jain T,
Kenderian SS
, Oluwole OO, Shah GL, Svoboda J, Hamadani M. Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther 2022 Sep; 28 (9):546-559 Epub 2022 June 26
View PubMed
Hampel PJ, Rabe KG, Call TG, Ding W, Leis JF, Chanan-Khan AA,
Kenderian SS
, Muchtar E, Wang Y, Ailawadhi S, Koehler AB, Parrondo R, Schwager SM, Sher T, Hanson CA, Shi M, Van Dyke DL, Braggio E, Slager SL, Kay NE, Parikh SA. Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib. Blood Cancer J. 2022 Sep 1; 12 (9):124 Epub 2022 Sept 01
View PubMed
Alkhateeb HB, Mohty R, Greipp P, Bansal R, Hathcock M, Rosenthal A, Murthy H, Kharfan-Dabaja M, Bisneto Villasboas JC, Bennani N, Ansell SM, Patnaik MM, Litzow MR, He R, Chen D, Al-Kali A,
Kenderian SS
, Lin Y, Shah MV. Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma. Blood Cancer J 2022 Jul 26; 12 (7):113 Epub 2022 July 26
View PubMed
Soof CM, Spektor TM, Parikh SA, Slager SL, Rabe KG, Call TG,
Kenderian SS
, Ding W, Muchtar E, Ghermezi M, Kay NE, Berenson JR. Serum B-Cell maturation antigen is an independent prognostic marker in previously untreated chronic lymphocytic leukemia. Exp Hematol. 2022 Jul; 111:32-40 Epub 2022 May 05
View PubMed
Sakemura R, Hefazi M, Siegler EL, Cox MJ, Larson DP, Hansen MJ, Manriquez Roman C, Schick KJ, Can I, Tapper EE, Horvei P, Adada MM, Bezerra ED, Kankeu Fonkoua LA, Ruff MW, Nevala WK, Walters DK, Parikh SA, Lin Y, Jelinek DF, Kay NE, Bergsagel PL,
Kenderian SS
. Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma. Blood. 2022 Jun 30; 139 (26):3708-3721
View PubMed
Kankeu Fonkoua LA, Sirpilla O, Sakemura R, Siegler EL,
Kenderian SS
. CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities. Mol Ther Oncolytics. 2022 Jun 16; 25:69-77 Epub 2022 Mar 19
View PubMed
Cox MJ, Manriquez Roman C, Tapper EE, Siegler EL, Chappell D, Durrant C, Ahmed O, Sinha S, Mwangi R, Scott NS, Hefazi M, Schick KJ, Horvei P, Ruff MW, Can I, Adada M, Bezerra E, Kankeu Fonkoua LA, Parikh SA, Kay NE, Sakemura R,
Kenderian SS
. GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity. Leukemia. 2022 Jun; 36(6):1635-1645. Epub 2022 Apr 19.
View PubMed
Can I, Cox MJ, Siegler EL, Sakemura R,
Kenderian SS
. Challenges of chimeric antigen receptor T-cell therapy in chronic lymphocytic leukemia: lessons learned. Exp Hematol. 2022 Apr; 108:1-7. Epub 2022 Feb 10.
View PubMed
Wang H, Tian S, Zhao Q, Blumenschein W, Yearley JH, Secreto CR, Sinha S, Call TG, Wang Y, Parikh SA,
Kenderian SS
, He R, Leis JF, Shi M, Van Dyke DL, Kay NE, Slager SL, Braggio E, Yan H, Ding W. Differential transcriptomic profiling in ibrutinib-naive versus ibrutinib-resistant Richter syndrome. Hematol Oncol 2022 Apr; 40 (2):302-306 Epub 2021 Dec 03
View PubMed
Sakemura R, Cox MJ, Bansal A, Roman CM, Hefazi M, Vernon CJ, Glynn DL, Pandey MK, DeGrado TR, Siegler EL,
Kenderian SS
. Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography. J Vis Exp. 2022 Feb 17; (180).
View PubMed
King RL, Gupta A, Kurtin PJ, Ding W, Call TG, Rabe KG,
Kenderian SS
, Leis JF, Wang Y, Schwager SM, Slager SL, Kay NE, Koehler A, Ansell SM, Inwards DJ, Habermann TM, Shi M, Hanson CA, Howard MT, Parikh SA. Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? Blood Cancer J. 2022 Jan 28; 12 (1):18
View PubMed
Muchtar E, Koehler AB, Johnson MJ, Rabe KG, Ding W, Call TG, Leis JF,
Kenderian SS
, Hayman SR, Wang Y, Hampel PJ, Holets MA, Darby HC, Slager SL, Kay NE, Miao C, Canniff J, Whitaker JA, Levin MJ, Schmid DS, Kennedy RB, Weinberg A, Parikh SA. Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis. Am J Hematol. 2022 Jan 1; 97 (1):90-98 Epub 2021 Nov 05
View PubMed
Sakemura R, Bansal A, Siegler EL, Hefazi M, Yang N, Khadka RH, Newsom AN, Hansen MJ, Cox MJ, Manriquez Roman C, Schick KJ, Can I, Tapper EE, Nevala WK, Adada MM, Bezerra ED, Kankeu Fonkoua LA, Horvei P, Ruff MW, Parikh SA, Pandey MK, DeGrado TR, Suksanpaisan L, Kay NE, Peng KW, Russell SJ,
Kenderian SS
. Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity. Cancer Immunol Res. 2021 Sep; 9(9):1035-1046. Epub 2021 Jul 08.
View PubMed
Shakshouk H, Tkaczyk ER, Cowen EW, El-Azhary RA, Hashmi SK,
Kenderian SJ
, Lehman JS. Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review. Transplant Cell Ther. 2021 Sep; 27 (9):738-746 Epub 2021 June 06
View PubMed
Sakemura R, Cox MJ, Hefazi M, Siegler EL,
Kenderian SS
. Resistance to CART cell therapy: lessons learned from the treatment of hematological malignancies. Leuk Lymphoma. 2021 Sep; 62(9):2052-2063. Epub 2021 Mar 08.
View PubMed
Wang Y, Achenbach SJ, Rabe KG, Shanafelt TD, Call TG, Ding W,
Kenderian SS
, Muchtar E, Leis JF, Koehler AB, Schwager SM, Cerhan JR, Slager SL, Kay NE, Parikh SA. Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index. Blood Cancer J 2021 Aug 5; 11 (8):140 Epub 2021 Aug 05
View PubMed
Parikh SA, Rabe KG, Kay NE, Call TG, Ding W, Leis JF,
Kenderian SS
, Muchtar E, Wang Y, Koehler AB, Schwager SM, Lesnick CE, Kleinstern G, Van Dyke D, Hanson CA, Braggio E, Slager SL, Shanafelt TD. The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL. Blood. 2021 Jul 15; 138 (2):149-159
View PubMed
Audil HY, Hampel PJ, Van Dyke DL, Achenbach SJ, Rabe KG, Smoley SA, Call TG, Ding W, Shi M, Hanson CA, Wang Y, Muchtar E, Koehler AB, Schwager SM, Leis JF, Braggio E, Slager SL, Kay NE,
Kenderian SS
, Parikh SA. The prognostic significance of del6q23 in chronic lymphocytic leukemia. Am J Hematol 2021 Jun 1; 96 (6):E203-E206 Epub 2021 Apr 07
View PubMed
Wang Y, Sinha S, Wellik LE, Secreto CR, Rech KL, Call TG, Parikh SA,
Kenderian SS
, Muchtar E, Hayman SR, Koehler AB, Van Dyke DL, Leis JF, Slager SL, Dong H, Kay NE, He R, Ding W. Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome. Blood Cancer J. 2021 May 10; 11 (5):86
View PubMed
Cox MJ, Lucien F, Sakemura R, Boysen JC, Kim Y, Horvei P, Manriquez Roman C, Hansen MJ, Tapper EE, Siegler EL, Forsman C, Crotts SB, Schick KJ, Hefazi M, Ruff MW, Can I, Adada M, Bezerra E, Kankeu Fonkoua LA, Nevala WK, Braggio E, Ding W, Parikh SA, Kay NE,
Kenderian SS
. Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia. Mol Ther. 2021 Apr 07; 29(4):1529-1540. Epub 2021 Jan 01.
View PubMed
Sakemura R, Can I, Siegler EL,
Kenderian SS
. In vivo CART cell imaging: Paving the way for success in CART cell therapy. Mol Ther Oncolytics. 2021 Mar 26; 20:625-633. Epub 2021 Mar 05.
View PubMed
Hampel PJ, Parikh SA, Call TG, Shah MV, Bennani NN, Al-Kali A, Rabe KG, Wang Y, Muchtar E, Leis JF,
Kenderian SS
, Koehler AB, Schwager SM, Slager SL, Kay NE, Hanson CA, Van Dyke DL, Shi M, Ding W. Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia. Blood Cancer J 2021 Mar 2; 11 (3):47 Epub 2021 Mar 02
View PubMed
Manriquez-Roman C, Siegler EL,
Kenderian SS
. CRISPR Takes the Front Seat in CART-Cell Development. BioDrugs. 2021 Mar; 35(2):113-124. Epub 2021 Feb 27.
View PubMed
Sinha S, Secreto CR, Boysen JC, Lesnick C, Wang Z, Ding W, Call TG,
Kenderian SJ
, Parikh SA, Warner SL, Bearss DJ, Ghosh AK, Kay NE. Upregulation of AXL and beta-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance. Blood Cancer J 2021 Feb 18; 11 (2):37
View PubMed
Archibald WJ, Rabe KG, Kabat BF, Herrmann J, Ding W, Kay NE,
Kenderian SS
, Muchtar E, Leis JF, Wang Y, Chanan-Khan AA, Schwager SM, Koehler AB, Fonder AL, Slager SL, Shanafelt TD, Call TG, Parikh SA. Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes. Ann Hematol. 2021 Jan; 100 (1):143-155 Epub 2020 June 01
View PubMed
Zahid A, Siegler EL,
Kenderian SS
. CART Cell Toxicities: New Insight into Mechanisms and Management. Clin Hematol Int. 2020 Dec; 2 (4):149-155 Epub 2020 Nov 23
View PubMed
Aboulnasr F, Krogman A, Graham RP, Cummins NW, Misra A, Garcia-Rivera E, Anderson JR, Natesampillai S, Kogan N, Aravamudan M, Nie Z, Chung TDY, Buick R, Feldman AL, King RL, Novak AJ, Ansell SM,
Kenderian S
, Badley AD. Human Cancers Express TRAILshort, a Dominant Negative TRAIL Splice Variant, Which Impairs Immune Effector Cell Killing of Tumor Cells. Clin Cancer Res. 2020 Nov 1; 26 (21):5759-5771 Epub 2020 July 15
View PubMed
Wang Y, Rabe KG, Bold MS, Shi M, Hanson CA, Schwager SM, Call TG,
Kenderian SS
, Muchtar E, Hayman SR, Koehler AB, Fonder AL, Chanan-Khan AA, Van Dyke DL, Slager SL, Kay NE, Ding W, Leis JF, Parikh SA. The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor. Haematologica 2020 Nov 1; 105 (11):2675-2678 Epub 2020 Nov 01
View PubMed
Hampel PJ, Call TG, Rabe KG, Ding W, Muchtar E,
Kenderian SS
, Wang Y, Leis JF, Witzig TE, Koehler AB, Fonder AL, Schwager SM, Van Dyke DL, Braggio E, Slager SL, Kay NE, Parikh SA. Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia. Oncologist. 2020 Nov; 25 (11):974-980 Epub 2020 Sept 20
View PubMed
Temesgen Z, Assi M, Shweta FNU, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Palraj R, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C,
Kenderian SS
, Badley AD. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 Nov; 95 (11):2382-2394 Epub 2020 Sept 03
View PubMed
Heybeli C, Sridharan M, Alkhateeb HB, Villasboas Bisneto JC, Buadi FK, Chen D, Dingli D, Dispenzieri A, Gertz MA, Go RS, Hashmi SK, Hayman SR, Hogan WJ, Inwards DJ,
Kenderian SS
, Kumar SK, Litzow MR, Porrata LF, Lacy MQ, Micallef IN, Patnaik MM, Shah MV, Leung N. Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2020 Oct; 95 (10):1170-1179 Epub 2020 Aug 08
View PubMed
Koehler AB, Leung N, Call TG, Rabe KG, Achenbach SJ, Ding W,
Kenderian SS
, Leis JF, Wang Y, Muchtar E, Hayman SR, Hampel PJ, Finnes HD, Schwager SM, Slager SL, Kay NE, Parikh SA. Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice. Leuk Lymphoma. 2020 Oct; 61 (10):2383-2388 Epub 2020 May 25
View PubMed
Mohty M, Dulery R, Gauthier J, Malard F, Brissot E, Aljurf M, Bazarbachi A, Chabanon C, Kharfan-Dabaja MA, Savani BN, Huang H,
Kenderian SS
, Perales MA, Yakoub-Agha I, Nagler A. CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview. Bone Marrow Transplant. 2020 Aug; 55 (8):1525-1532 Epub 2020 Apr 18
View PubMed
Klichinsky M, Ruella M, Shestova O, Lu XM, Best A, Zeeman M, Schmierer M, Gabrusiewicz K, Anderson NR, Petty NE, Cummins KD, Shen F, Shan X, Veliz K, Blouch K, Yashiro-Ohtani Y,
Kenderian SS
, Kim MY, O'Connor RS, Wallace SR, Kozlowski MS, Marchione DM, Shestov M, Garcia BA, June CH, Gill S. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat Biotechnol. 2020 Aug; 38 (8):947-953 Epub 2020 Mar 23
View PubMed
Temesgen Z, Assi M, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Varatharaj Palraj BR, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C,
Kenderian SS
, Badley A. First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia. medRxiv 2020 Jun 14 Epub 2020 June 14
View PubMed
Parikh SA, Achenbach SJ, Call TG, Rabe KG, Ding W, Leis JF,
Kenderian SS
, Chanan-Khan AA, Koehler AB, Schwager SM, Muchtar E, Fonder AL, McCullough KB, Nedved AN, Smith MD, Slager SL, Kay NE, Finnes HD, Shanafelt TD. The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice. Cancer Med. 2020 May; 9 (10):3390-3399 Epub 2020 Mar 18
View PubMed
Sterner RM, Hedin KE, Hayden RE, Nowakowski GS, Wyles SP, Greenberg-Worisek AJ, Terzic A,
Kenderian SS
. A Graduate-Level Interdisciplinary Curriculum in CAR-T Cell Therapy. Mayo Clin Proc Innov Qual Outcomes. 2020 Apr; 4 (2):203-210 Epub 2020 Mar 16
View PubMed
Wang Y, Tschautscher MA, Rabe KG, Call TG, Leis JF,
Kenderian SS
, Kay NE, Muchtar E, Van Dyke DL, Koehler AB, Schwager SM, Slager SL, Parikh SA, Ding W. Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center. Haematologica. 2020 Mar; 105 (3):765-773 Epub 2019 June 13
View PubMed
Hampel PJ, Call TG, Ding W, Muchtar E,
Kenderian SS
, Wang Y, Leis JF, Witzig TE, Koehler AB, Fonder AL, Schwager SM, Rabe KG, Van Dyke DL, Braggio E, Slager SL, Kay NE, Parikh SA. Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare. Am J Hematol 2020 Mar; 95 (3):E57-E60 Epub 2019 Dec 13
View PubMed
Sterner RM,
Kenderian SS
. Myeloid cell and cytokine interactions with chimeric antigen receptor-T-cell therapy: implication for future therapies. Curr Opin Hematol. 2020 Jan; 27 (1):41-48
View PubMed
Siegler EL,
Kenderian SS
. Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies. Front Immunol. 2020; 11:1973. Epub 2020 Aug 28.
View PubMed
Mohty M, Gautier J, Malard F, Aljurf M, Bazarbachi A, Chabannon C, Kharfan-Dabaja MA, Savani BN, Huang H,
Kenderian S
, Nagler A, Perales MA. CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives. Leukemia. 2019 Dec; 33 (12):2767-2778 Epub 2019 Nov 05
View PubMed
Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, Bollard CM, Komanduri KV, Gastineau DA, Chabannon C, Perales MA, Hudecek M, Aljurf M, Andritsos L, Barrett JA, Bachanova V, Bonini C, Ghobadi A, Gill SI, Hill JA,
Kenderian S
, Kebriaei P, Nagler A, Maloney D, Liu HD, Shah NN, Kharfan-Dabaja MA, Shpall EJ, Mufti GJ, Johnston L, Jacoby E, Bazarbachi A, DiPersio JF, Pavletic SZ, Porter DL, Grupp SA, Sadelain M, Litzow MR, Mohty M, Hashmi SK. Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT). Bone Marrow Transplant. 2019 Nov; 54 (11):1868-1880 Epub 2019 May 15
View PubMed
Hampel PJ, Ding W, Call TG, Rabe KG,
Kenderian SS
, Witzig TE, Muchtar E, Leis JF, Chanan-Khan AA, Koehler AB, Fonder AL, Schwager SM, Slager SL, Shanafelt TD, Kay NE, Parikh SA. Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice. Leuk Lymphoma. 2019 Nov; 60 (11):2712-2719 Epub 2019 Apr 24
View PubMed
Sterner RM, Cox MJ, Sakemura R,
Kenderian SS
. Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells. J Vis Exp. 2019 Jul 22; (149).
View PubMed
Khadka RH, Sakemura R,
Kenderian SS
, Johnson AJ. Management of cytokine release syndrome: an update on emerging antigen-specific T cell engaging immunotherapies. Immunotherapy. 2019 Jul; 11 (10):851-857 Epub 2019 June 04
View PubMed
Lehman JS, Dasari S, Damodaran SS, El-Azhary RA, Gibson LE, Hashmi SK, Hogan WJ,
Kenderian SJ
, Patnaik MS, Litzow MR, Lazarus HM, Meves A. Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skin. Clin Exp Dermatol. 2019 Jun; 44 (4):e81-e88 Epub 2018 Oct 02
View PubMed
Mochel JP, Ekker SC, Johannes CM, Jergens AE, Allenspach K, Bourgois-Mochel A, Knouse M, Benzekry S, Wierson W, LeBlanc AK,
Kenderian SS
. CAR T Cell Immunotherapy in Human and Veterinary Oncology: Changing the Odds Against Hematological Malignancies. AAPS J. 2019 Apr 8; 21 (3):50 Epub 2019 Apr 08
View PubMed
Fang H, Reichard KK, Rabe KG, Hanson CA, Call TG, Ding W,
Kenderian SS
, Muchtar E, Schwager SM, Leis JF, Chanan-Khan AA, Slager SL, Braggio E, Smoley SA, Kay NE, Shanafelt TD, Van Dyke DL, Parikh SA. IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes. Am J Hematol. 2019 Mar; 94 (3):338-345 Epub 2019 Jan 08
View PubMed
Sterner RM, Sakemura R, Cox MJ, Yang N, Khadka RH, Forsman CL, Hansen MJ, Jin F, Ayasoufi K, Hefazi M, Schick KJ, Walters DK, Ahmed O, Chappell D, Sahmoud T, Durrant C, Nevala WK, Patnaik MM, Pease LR, Hedin KE, Kay NE, Johnson AJ,
Kenderian SS
. GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts. Blood. 2019 Feb 14; 133 (7):697-709 Epub 2018 Nov 21
View PubMed
Vera-Aguilera J, Duma N, Gast K, Alkhateeb H, Tande A, Leung N, Hogan WJ,
Kenderian SJ
. Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient. Mayo Clin Proc Innov Qual Outcomes. 2018 Dec; 2 (4):387-391 Epub 2018 Sept 15
View PubMed
Rodriguez-Cartagena LG, Bowles BS, Kurani SS, Windebank AJ,
Kenderian SS
, Greenberg-Worisek AJ. Chimeric Antigen Receptor T-Cells: Successful Translation of the First Cell and Gene Therapy From Bench to Bedside. Clin Transl Sci. 2018 Nov; 11 (6):537-539 Epub 2018 Sept 22
View PubMed
Hampel PJ, Larson MC, Kabat B, Call TG, Ding W,
Kenderian SS
, Bowen D, Boysen J, Schwager SM, Leis JF, Chanan-Khan AA, Muchtar E, Hanson CA, Slager SL, Kay NE, Chaffee KG, Shanafelt TD, Parikh SA. Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre. Br J Haematol. 2018 Nov; 183 (3):421-427 Epub 2018 Aug 16
View PubMed
Perez Botero J, Ho TP, Hogan WJ,
Kenderian S
, Gangat N, Tefferi A, Abraham RS, Nguyen P, Oliveira JL, He R, Chen D, Viswanatha D, Rodriguez V, Khan SP, Patnaik MM. Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms. Br J Haematol. 2018 Jul; 182 (1):141-145 Epub 2017 May 09
View PubMed
Parikh SA, Chaffee KG, Larson MC, Hampel PJ, Call TG, Ding W,
Kenderian SS
, Leis JF, Chanan-Khan AA, Conte MJ, Bowen D, Schwager SM, Slager SL, Hanson CA, Kay NE, Shanafelt TD. Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis. Haematologica 2018 Jun; 103 (6):e237-e240 Epub 2018 Feb 01
View PubMed
Kim MY, Yu KR,
Kenderian SS
, Ruella M, Chen S, Shin TH, Aljanahi AA, Schreeder D, Klichinsky M, Shestova O, Kozlowski MS, Cummins KD, Shan X, Shestov M, Bagg A, Morrissette JJD, Sekhri P, Lazzarotto CR, Calvo KR, Kuhns DB, Donahue RE, Behbehani GK, Tsai SQ, Dunbar CE, Gill S. Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia. Cell. 2018 May 31; 173 (6):1439-1453.e19
View PubMed
Ruella M,
Kenderian SS
. Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf. BioDrugs. 2017 Dec; 31 (6):473-481
View PubMed
Hampel PJ, Chaffee KG, King RL, Simonetto D, Larson MC, Achenbach S, Call TG, Ding W,
Kenderian SS
, Leis JF, Chanan-Khan AA, Bowen DA, Conte MJ, Schwager SM, Hanson CA, Slager SL, Kay NE, Shanafelt TD, Parikh SA. Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings. Am J Hematol. 2017 Dec; 92 (12):1362-1369 Epub 2017 Oct 19
View PubMed
Ruella M, Klichinsky M,
Kenderian SS
, Shestova O, Ziober A, Kraft DO, Feldman M, Wasik MA, June CH, Gill S. Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells. Cancer Discov. 2017 Oct; 7 (10):1154-1167 Epub 2017 June 02
View PubMed
Finnes HD, Chaffee KG, Call TG, Ding W,
Kenderian SS
, Bowen DA, Conte M, McCullough KB, Merten JA, Bartoo GT, Smith MD, Leis J, Chanan-Khan A, Schwager SM, Slager SL, Kay NE, Shanafelt TD, Parikh SA. Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice. Leuk Lymphoma. 2017 Jun; 58 (6):1376-1383 Epub 2016 Nov 08
View PubMed
Tasian SK,
Kenderian SS
, Shen F, Ruella M, Shestova O, Kozlowski M, Li Y, Schrank-Hacker A, Morrissette JJD, Carroll M, June CH, Grupp SA, Gill S. Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia. Blood. 2017 Apr 27; 129 (17):2395-2407 Epub 2017 Feb 28
View PubMed
Kenderian SS
, Porter DL, Gill S. Chimeric Antigen Receptor T Cells and Hematopoietic Cell Transplantation: How Not to Put the CART Before the Horse. Biol Blood Marrow Transplant. 2017 Feb; 23 (2):235-246 Epub 2016 Sept 13
View PubMed
Tabibian JH,
Kenderian SS
. The Microbiome and Immune Regulation After Transplantation. Transplantation. 2017 Jan; 101 (1):56-62
View PubMed
Kenderian SS
, June CH, Gill S. Generating and Expanding Autologous Chimeric Antigen Receptor T Cells from Patients with Acute Myeloid Leukemia. Methods Mol Biol. 2017; 1633:267-276
View PubMed
Dias A,
Kenderian SJ
, Westin GF, Litzow MR. Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia. Curr Hematol Malig Rep. 2016 Aug; 11 (4):253-64
View PubMed
Ruella M,
Kenderian SS
, Shestova O, Fraietta JA, Qayyum S, Zhang Q, Maus MV, Liu X, Nunez-Cruz S, Klichinsky M, Kawalekar OU, Milone M, Lacey SF, Mato A, Schuster SJ, Kalos M, June CH, Gill S, Wasik MA. The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma. Clin Cancer Res. 2016 Jun 1; 22 (11):2684-96 Epub 2016 Jan 27
View PubMed
Kenderian SS
, Habermann TM, Macon WR, Ristow KM, Ansell SM, Colgan JP, Johnston PB, Inwards DJ, Markovic SN, Micallef IN, Thompson CA, Porrata LF, Martenson JA, Witzig TE, Nowakowski GS. Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution. Blood. 2016 Apr 21; 127 (16):1960-6 Epub 2016 Feb 02
View PubMed
Eskandar A, Ahmed A, Daughtey M,
Kenderian S
, Mahdi F, Khan A. Racial and sex differences in presentation and outcomes of small cell lung cancer in the United States: 1973 to 2010. Chest 2015 Apr; 147 (4):e164-e165
View PubMed
Rosado FG, Oliveira JL, Sohani AR, Schroyens W, Sykes DB,
Kenderian SS
, Lacy MQ, Kyle RA, Hoyer JD. Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist. Mod Pathol. 2015 Mar; 28 (3):367-72 Epub 2014 Sept 12
View PubMed
Kenderian SS
, Litzow M. Acute Lymphoblastic Leukemia in Adolescents and Young Adults: From Genomics to the Clinic Clinical Oncology in Adolescents and Young Adults .2013;2013:(3)49-62.
Sirop SJ
, Ingle JN, Goetz MP. Clinical use of selective estrogen receptor modulators and aromatase inhibitors in prevention and adjuvant treatment of bresat cancer. Translational Endocrincology and Metabolism, The Endocrine Society. 2012; 3(1):139-167.
Soni M, Wiese D, Korant A,
Sirop S
, Chakravarty B, Gayar A, Bilchik A, Beutler T, Ratz D, Saha S. Comparison of nodal positivity between SLNM vs conventional surgery in colon cancer patients with <12 and >/=12 lymph nodes harvested. Am J Surg. 2011 Aug; 202: (2)207-13.
View PubMed
Sirop S
, Kanaan M, Korant A, Wiese D, Eilender D, Nagpal S, Arora M, Singh T, Saha S. Detection and prognostic impact of micrometastasis in colorectal cancer. J Surg Oncol. 2011 May 1; 103: (6)534-7.
View PubMed
Saha S,
Sirop S
, Korant A, Kanaan M, Shekher R, Strahle D, Hicks M, Hicks R, Lawrence L, Wiese D. Nodal positivity in breast cancer correlated with the number of lesions detected by magnetic resonance imaging versus mammogram. Am J Surg. 2011 Mar; 201: (3)390-4; discussion 394-5.
View PubMed
Sirop SJ
, Haluska P. Insulin-like growth factor pathway-targeted therapy in breast cancer. Current Breast Cancer Reports. 2011; 3(1):6-14.
Wiese D,
Sirop S
, Yestrepsky B, Ghanem M, Bassily N, Ng P, Liu W, Quiachon E, Ahsan A, Badin J, Saha S. Ultrastaging of sentinel lymph nodes (SLNs) vs. non-SLNs in colorectal cancer--do we need both? Am J Surg. 2010 Mar; 199: (3)354-8; discussion 358.
View PubMed
Soni M, Saha S, Korant A, Fritz P, Chakravarty B,
Sirop S
, Gayar A, Iddings D, Wiese D. A prospective trial comparing 1% lymphazurin vs 1% methylene blue in sentinel lymph node mapping of gastrointestinal tumors. Ann Surg Oncol. 2009 Aug; 16: (8)2224-30.
View PubMed
Cahill RA, Bembenek A,
Sirop S
, Waterhouse DF, Schneider W, Leroy J, Wiese D, Beutler T, Bilchik A, Saha S, Schlag PM. Sentinel node biopsy for the individualization of surgical strategy for cure of early-stage colon cancer. Ann Surg Oncol. 2009 Aug; 16: (8)2170-80.
View PubMed
Wiese D, Saha S, Yestrepsky B, Korant A,
Sirop S
. A prospective study of false-positive diagnosis of micrometastatic cells in the sentinel lymph nodes in colorectal cancer. Ann Surg Oncol. 2009 Aug; 16: (8)2166-9.
View PubMed
.
Mayo Clinic Footer